Sign in

Lost your password?
(close)

Ipsen Russia

Last updated: 13.02.2014

Address: 19, Таганская ул., 109147, Москва, Россия,Russia

Tel: + 7 (495) 258 54 00

Web: http://www.ipsen.ru/

Company description

Mission statement and profile:

Ipsen is a global biopharmaceutical group, with sales exceeding 1.1 billion euros in 2010. The Group has total worldwide staff of more than 4,400 employees, of which more than 900 contribute to the discovery and development of innovative drugs for patient care.

Ipsen’s development strategy is based on fast growing specialty care drugs in oncology, endocrinology, neurology and hematology and on primary care drugs. This strategy is supported by an active policy of partnerships. Ipsen’s research & development (R&D) centers and its peptide & protein engineering platform give the Group a strong competitive edge. In 2010, R&D expenditure totaled more than €220 million, above 20% of Group sales.

Ipsen’s shares are traded on segment A of Euronext Paris (stock code: IPN, ISIN code: FR0010259150) and eligible to the “Service de Règlement Différé” (“SRD”). The Group is part of the SBF 120 index. Ipsen has implemented a Sponsored Level I American Depositary Receipt (ADR) program, which trade on the over-the-counter market in the United States under the symbol IPSEY. For more information on Ipsen, visit our website at www.ipsen.com.

Ipsen in Russia:

Ipsen operates in Russia since 1993. Currently the company is represented in the most of biggest cities of Russia, with a staff of about 200 person. The company portfolio in Russia includes products used in common therapeutic practice, as well as innovative drugs. For more information on Ipsen Pharma Russian Representative office please visit www.ipsen.ru

Products and services

The Group’s product portfolio includes pharmaceutical products marketed around the world to specialists working in its targeted therapeutic areas (oncology, endocrinology, neurology, hematology), which are its primary areas of development. The Group also markets products in other therapeutic areas in which it boasts longstanding expertise (gastroenterology, cardiovascular and cognitive disorders). To a large extent, these are composed of primary care.

Interviews

Related

We use cookies to ensure that we give you the best experience on our site. For more info click here